Analysis of DNA in Endometrial Cancer Cells Treated with Phyto-Estrogenic Compounds using Comparative Genomic Hybridisation Microarrays

Abstract

The aim of this study was to identify genomic aberrations in endometrial cancer cells treated with the phyto-estrogenic compounds tectorigenin, irigenin and apigenin and to compare with those treated with β-estradiol using array-based comparative genomic hybridisation (array CGH). The microarray contains 287 targets and includes telomeres, microdeletions, oncogenes and tumour suppressor genes and has increased mapping resolution compared to conventional CGH. An endometrial cancer cell line (Ishikawa) was cultured and treated with the phyto-estrogens. Treated cells were examined using the CGH microarray. Over 20 % of the array genes were aberrated in the cells treated with β-estradiol, tectorigenin and irigenin compared to 3 % in those treated with the same concentration of apigenin. Protein kinase c zeta form, insulin, insulin receptor and protein-tyrosine phosphatase non-receptor-type 1 which are involved in insulin metabolism were aberrated by tectorigenin and irigenin. Apigenin may play a role in the treatment of endometrial cancer and in the treatment of postmenopausal women. Further studies in normal endometrium and primary endometrial cancer cells are needed to elucidate the role of the phyto-estrogens.

Key words

Tectorigenin - irigenin - apigenin - β-estradiol - CGH microarray - endometrial cancer

References

• 1 Dunnick J K, Hailey J R. Toxicity and carcinogenicity studies of quercetin, a natural component of foods.  Fundam Appl Toxicol. 1992;  19 423-31
• 2 Adlercreutz H, Mazur W. Phyto-oestrogens and Western diseases.  Ann Med. 1997;  29 95-120
• 3 Ezaki S. Pharmacological studies of tectoridin and tectorigenin.  Nippon Yakurigaku Zasshi. 1968;  64 186-98
• 4 Seidlova-Wuttke D, Hesse O, Jarry H, Rimoldi G, Thelen P, Christoffel V. et al . Belamcanda chinensis and the thereof purified tectorigenin have selective estrogen receptor modulator activities.  Phytomedicine. 2004;  11 392-40
• 5 Milewicz A, Gejdel E, Sworen H, Sienkiewicz K, Jedrzejak J, Teucher T. et al . [Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study].  Arzneimittelforschung. 1993;  43 752-6
• 6 Jarry H, Spengler B, Porzel A, Schmidt J, Wuttke W, Christoffel V. Evidence for estrogen receptor beta-selective activity of Vitex agnus-castus and isolated flavones.  Planta Med. 2003;  69 945-7
• 7 Kallioniemi A, Kallioniemi O P, Sudar D, Rutovitz D, Gray J W, Waldman F. et al . Comparative genomic hybridization for molecular cytogenetic analysis of solid tumor.  Science. 1992;  258 818-21
• 8 du Manoir S, Schrock E, Bentz M, Speicher M R, Joos S, Ried T. et al . Quantitative analysis of comparative genomic hybridization.  Cytometry. 1995;  19 27-41
• 9 Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Dohner H. et al . Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances.  Genes, Chromosome and Cancer. 1997;  20 399-407
• 10 Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D. et al . High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays.  Nat Genet. 1998;  20 207-11
• 11 Albertson D G, Ylstra B, Segraves R, Collins C, Dairkee S H, Kowbel D. et al . Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene.  Nat Genet. 2000;  25 144-6
• 12 Hata H, Kuramoto H. Immunocytochemical determination of estrogen and progesterone receptors in human endometrial adenocarcinoma cells (Ishikawa cells).  J Steroid Biochem Mol Biol. 1992;  42 201-10
• 13 Zhu F, Liu X G, Liang N C. Effect of emodin and apigenin on invasion of human ovarian carcinoma HO-8910PM cells in vitro .  Ai Zheng. 2003;  22 358-62
• 14 Standaert M L, Galloway L, Karnam P, Bandyopadhyay G, Moscat J, Farese R V. Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport.  J Biol Chem. 1997;  272 30 075-82
• 15 Ahmad F, Li P M, Meyerovitch J, Goldstein B J. Osmotic loading of neutralizing antibodies demonstrates a role for protein-tyrosine phosphatase 1B in negative regulation of the insulin action pathway.  J Biol Chem. 1995;  270 20 503-8
• 16 Jung S H, Lee Y S, Lee S, Lim S S, Kim Y S, Shin K H. Isoflavonoids from the rhizomes of Belamcanda chinensis and their effects on aldose reductase and sorbitol accumulation in streptozotocin induced diabetic rat tissues.  Arch Pharm Res. 2002;  25 306-12
• 17 Godsland I F, Manassiev N A, Felton C V, Proudler A J, Crook D, Whitehead M I. et al . Effects of low and high dose oestradiol and dydrogesterone therapy on insulin and lipoprotein metabolism in healthy postmenopausal women.  Clin Endocrinol (Oxf). 2004;  60 541-9
• 18 Pere H, Tapper J, Wahlstrom T, Knuutila S, Butzow R. Distinct chromosomal imbalances in uterine serous and endometrioid carcinomas.  Cancer Res. 1998;  58 892-5
• 19 Sonoda G, du Manoir S, Godwin A K, Bell D W, Liu Z, Hogan M. et al . Detection of DNA gains and losses in primary endometrial carcinomas by comparative genomic hybridization.  Genes Chromosomes Cancer. 1997;  18 115-25
• 20 Suzuki A, Fukushige S, Nagase S, Ohuchi N, Satomi S, Horii A. Frequent gains on chromosome arms 1q and/or 8q in human endometrial cancer.  Hum Genet. 1997;  100 629-36